Molecular studies on schwannomatosis

Monographs in Human Genetics

Volumn 16, Issue , 2008, Pages 177-188

  Kluwe, L ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870158746     PISSN: 00770876     EISSN: 16623835     Source Type: Book Series    
DOI: 10.1159/000126616     Document Type: Article

References (19)

1. Evans DG, Huson SM, Donnai D, Neary W, Blair V, et al: A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet 1992;29:847-852. (Pubitemid 23035206)
2. MacCollin M, Woodfin W, Kronn D, Short MP: Schwannomatosis: a clinical and pathologic study. Neurology 1996;46:1072-1079. (Pubitemid 26134655)
3. Mautner VF, Lindenau M, Baser ME, Hazim W, Tatagiba M, et al: The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 1996;38:880-885.
4. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N: Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 1994;52:450-461. (Pubitemid 24298996)
5. Mautner VF, Lindenau M, Baser ME, Kluwe L, Gottschalk J: Skin abnormalities in neurofibromatosis 2. Arch Dermatol 1997;133:1539-1543. (Pubitemid 27525732)
6. Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J: Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 2000;54:71-76. (Pubitemid 30038740)
7. MacCollin M, Chiocca EA, Evans DG, Friedman JM, Horvitz R, et al: Diagnostic criteria for schwannomatosis. Neurology 2005;64:1838-1845. (Pubitemid 40800695)
8. Leverkus M, Kluwe L, Roll EM, Becker G, Brocker EB, Mautner VF, Hamm H: Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis? Br J Dermatol 2003;148:804-809. (Pubitemid 36629763)
9. Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio MP, et al: Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 1994;3:413-419. (Pubitemid 24083900)
10. Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella JF: Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer 1996;17:45-55. (Pubitemid 26327934)
11. Kluwe L, Mautner VF: Mosaicism in sporadic neurofibromatosis 2 patients. Hum Mol Genet 1998;7:2051-2055. (Pubitemid 28546413)
12. Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, MacCollin M: Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 1997;61:1293-1302. (Pubitemid 28046905)
13. Kaufman DL, Heinrich BS, Willett C, Perry A, Finseth F, Sobel RA, MacCollin M: Somatic instability of the NF2 gene in schwannomatosis. Arch Neurol 2003;60:1317-1320. (Pubitemid 37099643)
14. MacCollin M, Willett C, Heinrich B, Jacoby LB, Acierno JS Jr, Perry A, Louis DN: Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology 2003;60:1968-1974. (Pubitemid 36736014)
15. Warren C, James LA, Ramsden RT, Wallace A, Baser ME, Varley JM, Evans DG: Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation. J Med Genet 2003;40:802-806. (Pubitemid 37485489)
16. Kluwe L, Friedrich RE, Hagel C, Lindenau M, Mautner V-F: Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors. J Invest Dermatol 2000;114:1017-1021. (Pubitemid 30252726)
17. Hulsebos T J M, Plomp AS, Wolterman RA, Robanus-Maandag EC, Baas F, Wesseling P: Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 2007;80:805-810. (Pubitemid 46564417)
18. Buckley PG, Mantripragada KK, Diaz De Stahl T, Piotrowski A, Hansson CM, et al: Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2. Hum Mutat 2005;26:540-549. (Pubitemid 41780476)
19. Roberts CW, Orkin SH: The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer 2004;4:133-142.